Weiss Ratings reissued their sell (e+) rating on shares of SCWorx (NASDAQ:WORX – Free Report) in a research note released on Wednesday,Weiss Ratings reports.
Separately, Wall Street Zen upgraded SCWorx to a “sell” rating in a research report on Saturday, June 14th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, SCWorx has an average rating of “Sell”.
View Our Latest Stock Report on SCWorx
SCWorx Stock Down 11.3%
SCWorx (NASDAQ:WORX – Get Free Report) last issued its quarterly earnings results on Thursday, August 14th. The company reported ($0.44) earnings per share (EPS) for the quarter. The company had revenue of $0.68 million during the quarter. SCWorx had a negative net margin of 105.74% and a negative return on equity of 58.42%.
SCWorx Company Profile
SCWorx Corp. develops and markets health care information technology solutions and related services to improve healthcare processes and information flow within hospitals and other healthcare facilities in the United States. The company provides data content and services related to repair, normalization, and interoperability of information for healthcare providers, as well as big data analytics for the healthcare industry.
Read More
- Five stocks we like better than SCWorx
- What is a Special Dividend?
- 3 Heavily Shorted Stocks That Could Pop on Rate Cuts
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- Broadcom Gets Second $420 Target as CPO Win Boosts Outlook
- Insider Trading – What You Need to Know
- PepsiCo’s Deep Discount Will Soon Evaporate: Buy It While You Can
Receive News & Ratings for SCWorx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SCWorx and related companies with MarketBeat.com's FREE daily email newsletter.